Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

809126

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Skin Diseases
house id	1
legislature	25259 pref label House of Commons
question text	What estimate he has made of the number of patients with Erythropoietic Protoporphyria.
tabling member constituency	Newport East
tabling member printed	Jessica Morden
uin	903031
answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>In 2016/17 there were 54 National Health Service admissions in England with a primary diagnosis of Erythropoietic Protoporphyria.</p><p> </p><p>Whilst the numbers of people with a particular rare disease can be very small, 3.5 million people in the United Kingdom have a rare disease. We know, as with the hon. Member’s constituent, that these diseases can have a heart-breaking impact on a person’s health.</p><p> </p><p>That‘s why the UK is committed to building on our position as a world-leader in the diagnosis and treatment of rare diseases.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:07:30 answering member 4067 label Biography information for Steve Brine
tabling member	1548 label Biography information for Jessica Morden

809129

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Fees and Charges
house id	1
legislature	25259 pref label House of Commons
question text	What recent assessment he has made of trends in the level of fines in relation to dental and prescription charges.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	903036
answer	answer is ministerial correction date of answer 19/12/2017 answer text <p>The NHS Business Services Authority (NHS BSA) issues penalty charge notices (PCNs) for incorrect claims for exemption from National Health Service dental and prescription charges.</p><p>To ensure the integrity of the exemption system the NHS BSA has recently increased the number of checks. In 2016/17, 365,181 PCNs for dental charges and 975,065 for prescription charges were issued. This represents an increase of 90.11% and 90.23%, respectively, on 2015/16. There is a clear process for patients to appeal a PCN if they believe it is unjustified.</p><p> </p> answering member constituency Winchester answering member printed Steve Brine question first answered 19/12/2017 17:09:22 answering member 4067 label Biography information for Steve Brine
tabling member	4471 label Biography information for Rachael Maskell

809547

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the level of availability of cancer gene tests is on the NHS; and whether the NHS prioritises such tests for people whose families have a history of cancer.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	120205
answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>NHS England is committed to implementing the Independent Cancer Taskforce’s recommendations on molecular diagnostics, meaning that around 25,000 additional people will have their cancers genetically tested every year to identify the most effective treatments. NHS England will continue to invest in building the infrastructure for genomics and by the end of 2018/19, will have developed a genomic medicine service for England, underpinned by a new consolidated genomic laboratory infrastructure and facilitated by informatics, data and analytical platforms to enable the sequencing data we generate to improve clinical practice. Once established, the new genomic laboratory infrastructure for the National Health Service in England will support rare, inherited and acquired disease, to support the NHS to deliver personalised medicine to all eligible patients.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 11:43:14 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

809601

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what support his Department plans to offer to those NHS trusts in those areas unlikely to be able to offer mechanial thrombectomy as a treatment immediately.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	120249
answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>NHS England does not anticipate being able to offer thrombectomy to all eligible stroke patients immediately, because of the need to develop and train further specialists to undertake the procedure. NHS England is initially proposing to set up 24 thrombectomy centres providing care 24 hours a day, seven days a week which would require a minimum of five interventional clinicians for each centre (120 clinicians). Ultimately NHS England expects to need at least 30 centres to provide equitable geographical coverage, which would require 150 interventionists.</p><p>NHS England anticipates that it will take a minimum of five years to achieve full 24/7 services and in the initial roll out phase of implementation most services will not be in a position to safely deliver this service 24/7, as delivering thrombectomy is a complex and highly technical procedure.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120250 question first answered 22/12/2017 11:41:14 answering member 4067 label Biography information for Steve Brine
tabling member	4124 label Biography information for Chi Onwurah

809604

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mechanical Thrombectomy
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how his Department plans to ensure that eligible stroke patients get access to mechanical thrombectomy treatment.
tabling member constituency	Newcastle upon Tyne Central
tabling member printed	Chi Onwurah
uin	120250
answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>NHS England does not anticipate being able to offer thrombectomy to all eligible stroke patients immediately, because of the need to develop and train further specialists to undertake the procedure. NHS England is initially proposing to set up 24 thrombectomy centres providing care 24 hours a day, seven days a week which would require a minimum of five interventional clinicians for each centre (120 clinicians). Ultimately NHS England expects to need at least 30 centres to provide equitable geographical coverage, which would require 150 interventionists.</p><p>NHS England anticipates that it will take a minimum of five years to achieve full 24/7 services and in the initial roll out phase of implementation most services will not be in a position to safely deliver this service 24/7, as delivering thrombectomy is a complex and highly technical procedure.</p><p> </p><p> </p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 120249 question first answered 22/12/2017 11:41:14 answering member 4067 label Biography information for Steve Brine
tabling member	4124 label Biography information for Chi Onwurah

809659

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Transport
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to Age UK’s Painful Journeys campaign, what steps his Department is taking to make travelling to and from hospital easier for older people.
tabling member constituency	Sheffield Central
tabling member printed	Paul Blomfield
uin	120279
answer	answer is ministerial correction date of answer 27/12/2017 answer text <p>The provision of appropriate patient transport services (PTS) in line with national guidance is a matter for local National Health Service commissioners.</p><p> </p><p>The Department is clear that medically eligible patients must have appropriate access to quality PTS to outpatient appointments. The document ‘Eligibility Criteria for Patient Transport Services’ sets out criteria for establishing which patients are eligible for non-emergency PTS. The guidance states that eligible patients should reach appointments in reasonable time and in reasonable comfort, without detriment to their medical condition.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/12/2017 11:03:11 answering member 4067 label Biography information for Steve Brine
tabling member	4058 label Biography information for Paul Blomfield

809872

registered interest
date	19/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken to ensure that the training of GPs includes the latest evidence on how to diagnose and treat ME.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	120492
answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>The postgraduate training curriculum of doctors is set by the relevant Royal College and has to meet the standards set by the General Medical Council (GMC). It emphasises the skills and attributes that a doctor must develop in order to ensure accurate and timely diagnoses and to develop a treatment plan to meet patients’ needs.</p><p> </p><p>The GMC published revised standards for postgraduate training curricula in May 2017. These provide an integrated standards framework for the development, approval and provision of postgraduate medical education and training in the United Kingdom.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 11:39:17 answering member 4067 label Biography information for Steve Brine
tabling member	252 label Biography information for Dr David Drew

808779

registered interest
date	18/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Arthritis: Vitamin D
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with (a) the Royal College of Nursing and (b) other bodies on the potential merits of prescribing vitamin D to patients with arthritis.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	119888
answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>No discussions have taken place.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 12:05:16 answering member 4067 label Biography information for Steve Brine
tabling member	4131 label Biography information for Jim Shannon

808797

registered interest
date	18/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescription Drugs: Prices
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, for what reasons there was insufficient stock to confer No Cheaper Stock Obtainable (NCSO) status on a 28 pack of 5mg Amlodipine.
tabling member constituency	Fylde
tabling member printed	Mark Menzies
uin	119906
answer	answer is ministerial correction date of answer 21/12/2017 answer text <p>In November the market price of amlodipine 5mg tablets was above the reimbursement price listed in the Drug Tariff, therefore the Secretary of State for Health granted a concessionary price. Supplies of amlodipine 5mg remain available from several suppliers.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/12/2017 17:45:43 answering member 4067 label Biography information for Steve Brine
tabling member	3998 label Biography information for Mark Menzies

808802

registered interest
date	18/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Spondyloarthritis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to improve the collection of data within the NHS at the (a) national and (b) local level on the incidence, prevalence and outcomes of ankylosing spondylitis and psoriatic arthritis.
tabling member constituency	Linlithgow and East Falkirk
tabling member printed	Martyn Day
uin	119911
answer	answer is ministerial correction date of answer 22/12/2017 answer text <p>Psoriatic arthritis and ankylosing spondylitis are part of group of musculoskeletal conditions referred to collectively as spondyloarthritis. This term also refers to conditions including: reactive arthritis; enteropathic arthritis; and undifferentiated spondyloarthritis. The National Institute for Health and Care Excellence advises that spondyloarthritis has a reported prevalence in Western Europe of between 0.8% in 1.7%.</p><p> </p><p>Improving Lives - the Work, Health and Disability Green Paper, published on 31 October 2016, set out the Government’s commitment to work with NHS England to identify opportunities for regular collection of data about incidence, prevalence, clinical activity and outcomes of musculoskeletal conditions and services in England. The Government’s Mandate to NHS England reiterated this commitment. On 30 November 2017 the Government published Improving Lives - The Future of Work, Health and Disability in response to the Green Paper. In building on the commitment in the Green Paper to identify opportunities for routine data collection about musculoskeletal incidence, prevalence, clinical activity, and outcomes, the report set out that a data advisory group, led by Arthritis Research UK, has been examining the issue. On 1 December 2017 the advisory group presented its recommendations to NHS England, which is currently considering the appropriate next steps. Improving Lives - The Future of Work, Health and Disability can be found at the following link:</p><p><a href="http://www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability" target="_blank">www.gov.uk/government/publications/improving-lives-the-future-of-work-health-and-disability</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/12/2017 12:59:01 answering member 4067 label Biography information for Steve Brine
tabling member	4488 label Biography information for Martyn Day